Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.

NCT ID: NCT00429884

Last Updated: 2008-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate if breathing disorders are related to atrial fibrillation and if it is possible to predict recurrence of atrial fibrillation after DC-conversion by changes in heart rate variability and 24 hour ECG.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Atrial fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* persistent atrial fibrillation
* scheduled for electrical cardioversion

Exclusion Criteria

* known obstructive sleep apnea
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umeå University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steen M Jensen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Heart Centre, Umeå University Hospital

Niklas G Höglund, MD

Role: PRINCIPAL_INVESTIGATOR

Heart Centre, Umeå University Hospital

Karl Franklin, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Umeå University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart Centre, Umeå University Hospital

Umeå, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Niklas G Höglund, MD

Role: CONTACT

Phone: +46907852729

Email: [email protected]

Steen M Jensen, MD, PhD

Role: CONTACT

Phone: +46907852729

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Niklas Höglund, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Hoglund N, Sahlin C, Kesek M, Jensen SM, Franklin KA. Cardioversion of atrial fibrillation does not affect obstructive sleep apnea. Ups J Med Sci. 2017 Jun;122(2):114-118. doi: 10.1080/03009734.2017.1291545. Epub 2017 Mar 14.

Reference Type DERIVED
PMID: 28291376 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05-027M

Identifier Type: -

Identifier Source: org_study_id